RIYADH · SAUDI ARABIA
Dr. Younes
Ben Said
Senior Pharmaceutical Executive · Industrial Management
A decade of international practice across Saudi Arabia, the UAE, Tunisia and Russia — bridging clinical research with commercial execution, and translating regulatory complexity into market access.
Drag a capsule around the tablet →
PROFILE
Where the molecule meets the market
Trained as a clinical pharmacist and holding a doctorate in industrial management, Dr. Ben Said works at the junction most organisations struggle to staff — where scientific evidence has to survive contact with regulation, reimbursement and commercial reality.
Clinical data is only as valuable as the regulatory pathway that carries it to a patient.
His doctoral and master’s theses examined how pharmaceutical products are promoted in the retail market — work that now underpins mandates in market access, IP lifecycle strategy and promotional compliance across the Gulf.
MARKET ACCESS
Which door does the dossier go through?
Choose a market and a submission type — the authority, the review clock and the required modules change with it.
MARKET
SUBMISSION TYPE
INDICATIVE REVIEW WINDOWS · ACTUAL TIMELINES VARY BY DOSSIER
CAREER
A decade of practice, orbiting one question:
how does evidence reach a patient?
RESEARCH
Peer-reviewed publications
Seven indexed papers spanning pharmaceutical marketing, digital health, diagnostics and sports medicine. ORCID 0009-0002-6724-5371.
ENGAGEMENTS
Six ways to work together
The expertise on the tablet, turned into defined pieces of work.
EDUCATION
Three degrees, two continents
Languages
ACADEMIC CONTRIBUTION
REVIEWED
Teaching, review and grants
Fourteen entries across five kinds of contribution. Choose a category to open it.
METHOD
Three ways evidence travels
A side-by-side comparison of how the same dossier is carried into three different decisions.
Regulatory
Translucent by design — every claim traceable to the study that produced it, nothing hidden behind the layer.
REGULATORY
COMMERCIAL
Scientific
Fluid and adaptive — the same evidence reshaped for the clinician, the payer and the peer reviewer.
SCIENTIFIC